Kairos Pharma’s goal is to intervene early in resistance and re-sensitize cancer cells to therapy: CEO October 14, 2025
JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q3 2025 financial results October 14, 2025
Our differentiation is validated by strong, sustainable unit economics: Prenetics CEO October 9, 2025
Inspire Veterinary Partners has a focus on long-term relationship with stakeholders: CEO September 18, 2025
